FDA.reportPublic FDA data

Pomalyst 2 MG Oral Capsule

RxCUI
1369728
RxNorm name
Pomalyst 2 MG Oral Capsule
Display name
Pomalyst 2 MG Oral Capsule
Full name
Pomalyst 2 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PomalystPOMALIDOMIDECelgene Corporation2b25ef01-5c9e-11e1-b86c-0800200c9a662025-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369728

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2b25ef01-5c9e-11e1-b86c-0800200c9a66Pomalyst 2 MG Oral CapsulePSN26These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 201320250226
2b25ef01-5c9e-11e1-b86c-0800200c9a66pomalidomide 2 MG Oral Capsule [Pomalyst]SBD26These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 201320250226
2b25ef01-5c9e-11e1-b86c-0800200c9a66Pomalyst 2 MG Oral CapsuleSY26These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 201320250226